Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Bourgeois, Melissa A ^a   Denslow, Nancy D ^a   Seino, Kathy S ^b   Barber, David S ^a   Long, Maureen T ^a  

^a University of Florida College of Veterinary Medicine   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUTAMIC ACID; NEUROTRANSMITTER; PENTAXIN 3; RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; INTERLEUKIN 15; MESSENGER RNA; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTIG MAPPING; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; EXCITOTOXICITY; EXPERIMENTAL INFECTION; EXPRESSED SEQUENCE TAG; FLAVIVIRUS INFECTION; GENE EXPRESSION; GENE LIBRARY; GENE MAPPING; HORSE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOID TISSUE; MENTAL DISEASE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE DATABASE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SURVIVAL RATE; THALAMUS; TRANSCRIPTOMICS; VIRUS ENCEPHALITIS; WEST NILE VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; BRAIN; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; REPRODUCIBILITY; VIROLOGY; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

EQUIDAE; WEST NILE VIRUS;

ANIMALS; CEREBRUM; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORSES; HUMANS; INTERLEUKIN-15; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, DOPAMINE; RECEPTORS, GLUTAMATE; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; THALAMUS; TRANSCRIPTOME; WEST NILE FEVER; WEST NILE VIRUS;

EID: 80053520937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024371     Document Type: Article

References (39)

1. U.S. Department of Agriculture (USDA) (2011) USDA APHIS Animal Health Monitoring and Surveillance West Nile Virus. http://www.aphis.usda.gov/vs/nahss/equine/wnv/. Accessed: 2011 May 01.
2. Center for Disease Control and Prevention (CDC) (2011) CDC West Nile Virus Statistics, Surveillance, and Control. http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount11_detailed.htm. Accessed: 2011 May 01.
3. Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, et al. (2006) West Nile virus neuroinvasive disease. Ann Neurol 60: 286-300.
4. Long MT, Gibbs EP, Mellencamp MW, Zhang S, Barnett DC, et al. (2007) Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses. Equine Vet J 39: 486-490.
5. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, et al. (2005) Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79: 11457-11466.
6. Wang Y, Lobigs M, Lee E, Mullbacher A, (2003) CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77: 13323-13334.
7. Porter MB, Long MT, Getman LM, Giguere S, MacKay RJ, et al. (2003) West Nile virus encephalomyelitis in horses: 46 cases (2001). J Am Vet Med Assoc 222: 1241-1247.
8. Xiao WW, Ma WL, Ma XD, Mao XM, Zheng WL, (2003) [Bioinformatic analysis of dengue virus cDNAs and design of oligonucleotide probes for microarray detection of the virus]. Di Yi Jun Yi Da Xue Xue Bao 23: 905-907.
9. Korimbocus J, Scaramozzino N, Lacroix B, Crance JM, Garin D, et al. (2005) DNA probe array for the simultaneous identification of herpesviruses, enteroviruses, and flaviviruses. J Clin Microbiol 43: 3779-3787.
10. Nordstrom H, Falk KI, Lindegren G, Mouzavi-Jazi M, Walden A, et al. (2005) DNA microarray technique for detection and identification of seven flaviviruses pathogenic for man. J Med Virol 77: 528-540.
11. Grinev A, Daniel S, Laassri M, Chumakov K, Chizhikov V, et al. (2008) Microarray-based assay for the detection of genetic variations of structural genes of West Nile virus. J Virol Methods 154: 27-40.
12. Gupta N, Santhosh SR, Babu JP, Parida MM, Rao PV, (2010) Chemokine profiling of Japanese encephalitis virus-infected mouse neuroblastoma cells by microarray and real-time RT-PCR: implication in neuropathogenesis. Virus Res 147: 107-112.
13. Lefeuvre A, Contamin H, Decelle T, Fournier C, Lang J, et al. (2006) Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Microbes Infect 8: 1530-1538.
14. Liew KJ, Chow VT, (2006) Microarray and real-time RT-PCR analyses of a novel set of differentially expressed human genes in ECV304 endothelial-like cells infected with dengue virus type 2. J Virol Methods 131: 47-57.
15. Moreno-Altamirano MM, Romano M, Legorreta-Herrera M, Sanchez-Garcia FJ, Colston MJ, (2004) Gene expression in human macrophages infected with dengue virus serotype-2. Scand J Immunol 60: 631-638.
16. Nasirudeen AM, Liu DX, (2009) Gene expression profiling by microarray analysis reveals an important role for caspase-1 in dengue virus-induced p53-mediated apoptosis. J Med Virol 81: 1069-1081.
17. Ubol S, Chareonsirisuthigul T, Kasisith J, Klungthong C, (2008) Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology 376: 290-296.
18. Glaser KE, Sun Q, Wells MT, Nixon AJ, (2009) Development of a novel equine whole transcript oligonucleotide GeneChip microarray and its use in gene expression profiling of normal articular-epiphyseal cartilage. Equine Vet J 41: 663-670.
19. Koh WL, Ng ML, (2005) Molecular mechanisms of West Nile virus pathogenesis in brain cell. Emerg Infect Dis 11: 629-632.
20. Venter M, Myers TG, Wilson MA, Kindt TJ, Paweska JT, et al. (2005) Gene expression in mice infected with West Nile virus strains of different neurovirulence. Virology 342: 119-140.
21. Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, et al. (2007) Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model. Equine Vet J 39: 491-497.
22. Seino KK, Long MT, Gibbs EP, Bowen RA, Beachboard SE, et al. (2007) Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model. Clin Vaccine Immunol 14: 1465-1471.
23. Blakely PK, Kleinschmidt-DeMasters BK, Tyler KL, Irani DN, (2009) Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J Neuropathol Exp Neurol 68: 1061-1072.
24. Darman J, Backovic S, Dike S, Maragakis NJ, Krishnan C, et al. (2004) Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci 24: 7566-7575.
25. Erdmann NB, Whitney NP, Zheng J, (2006) Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase. Clin Neurosci Res 6: 315-328.
26. Kaul M, (2008) HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci 13: 2484-2494.
27. Kaul M, Lipton SA, (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4: 307-318.
28. Bene R, Antic S, Budisic M, Lisak M, Trkanjec Z, et al. (2009) Parkinson's disease. Acta Clin Croat 48: 377-380.
29. Sellon D, Long MT, eds. (2007) Equine Infectious Diseases St. Louis, MO Elsevier.
30. Boyman O, Letourneau S, Krieg C, Sprent J, (2009) Homeostatic proliferation and survival of naive and memory T cells. Eur J Immunol 39: 2088-2094.
31. Rodrigues L, Bonorino C, (2009) Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies. Expert Rev Vaccines 8: 167-177.
32. Rodrigues L, Nandakumar S, Bonorino C, Rouse BT, Kumaraguru U, (2009) IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Mol Immunol 46: 1494-1504.
33. van Leeuwen EM, Sprent J, Surh CD, (2009) Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol 21: 167-172.
34. Yoneyama M, Fujita T, (2010) Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20: 4-22.
35. Baker BJ, Akhtar LN, Benveniste EN, (2009) SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 30: 392-400.
36. Mansfield KL, Johnson N, Cosby SL, Solomon T, Fooks AR, (2010) Transcriptional upregulation of SOCS 1 and suppressors of cytokine signaling 3 mRNA in the absence of suppressors of cytokine signaling 2 mRNA after infection with West Nile virus or tick-borne encephalitis virus. Vector Borne Zoonotic Dis 10: 649-653.
37. Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, et al. (2006) Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108: 3387-3396.
38. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, et al. (2008) Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 180: 3391-3398.
39. Matter C, Pribadi M, Liu X, Trachtenberg JT, (2009) Delta-catenin is required for the maintenance of neural structure and function in mature cortex in vivo. Neuron 64: 320-327.